Micro-array chip analysis of carbonyl-metabolising enzymes in normal, immortalised and malignant human oral keratinocytes

Abstract. Enzymes involved in various protective and metabolic processes of carbonyl compounds were analysed utilising a micro-array method in a three-stage in vitro model for oral carcinogenesis involving cultured normal, immortalised and malignant human oral keratinocytes. A complete transcript profiling of identified carbonyl-metabolising enzymes belonging to the ADH, ALDH, SDR and AKR families is presented. Expression of 17 transcripts was detected in normal, 14 in immortalized and 19 in malignant keratinocytes of a total of 12,500 genes spotted on the micro-array chip. For the detected transcripts, about half were changed by cell transformation, and for the various enzyme families, differences in expression patterns were observed. The detected AKR transcripts displayed a conserved pattern of expression, indicating a requirement for the keratinocyte phenotype, while most of the detected SDRs displayed changed expression at the various stages of malignancy. The importance of multiple experiments in using a micro-array technique for reliable results is underlined and, finally, the strength of the method in detecting co-expressed enzymes in metabolic pathways is exemplified by the detection of the formaldehyde-scavenging pathway enzymes and the polyol pathway enzymes.

[1]  C. Betsholtz,et al.  Characterization of human buccal epithelial cells transfected with the simian virus 40 T-antigen gene. , 1995, Carcinogenesis.

[2]  R. Grafström,et al.  Serum-free growth and karyotype analyses of cultured normal and tumorous (SqCC/Y1) human buccal epithelial cells. , 1991, Cancer communications.

[3]  D. Crabb,et al.  Distribution of messenger RNAs for aldehyde dehydrogenase 1, aldehyde dehydrogenase 2, and aldehyde dehydrogenase 5 in human tissues. , 1996, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[4]  H. Jörnvall,et al.  Forms and functions of human SDR enzymes. , 2001, Chemico-biological interactions.

[5]  V. Vasiliou,et al.  Polymorphisms of human aldehyde dehydrogenases. Consequences for drug metabolism and disease. , 2000, Pharmacology.

[6]  U. Oppermann,et al.  Molecular and structural aspects of xenobiotic carbonyl metabolizing enzymes. Role of reductases and dehydrogenases in xenobiotic phase I reactions. , 2000, Toxicology.

[7]  S. Yin,et al.  Expression and activities of class IV alcohol dehydrogenase and class III aldehyde dehydrogenase in human mouth. , 1996, Alcohol.

[8]  J. Jez,et al.  The aldo-keto reductase (AKR) superfamily: an update. , 2001, Chemico-biological interactions.

[9]  B. Persson,et al.  Pharmacogenetics of the Alcohol Dehydrogenase System , 2000, Pharmacology.

[10]  G. Duester Involvement of Alcohol Dehydrogenase, Short-Chain Dehydrogenase/Reductase, Aldehyde Dehydrogenase, and Cytochrome P450 in the Control of Retinoid Signaling by Activation of Retinoic Acid Synthesis† , 1996 .

[11]  A. Pfeifer,et al.  18 – Drug Metabolism and Carcinogen Activation Studies with Human Genetically Engineered Cells , 1996 .

[12]  H. Jörnvall,et al.  Recommended nomenclature for the vertebrate alcohol dehydrogenase gene family. , 1999, Biochemical pharmacology.

[13]  R. Grafström,et al.  Expression of keratins in normal, immortalized and malignant oral epithelia in organotypic culture. , 2001, Oral oncology.

[14]  R. Grafström,et al.  Growth and transformation of human oral epithelium in vitro. , 1997, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[15]  B. Persson,et al.  SDR and MDR: completed genome sequences show these protein families to be large, of old origin, and of complex nature , 1999, FEBS letters.

[16]  S. Svensson,et al.  Alcohol dehydrogenase in human tissues: localisation of transcripts coding for five classes of the enzyme , 1996, FEBS letters.

[17]  R. Grafström,et al.  Expression of alcohol dehydrogenase 3 in tissue and cultured cells from human oral mucosa. , 2000, The American journal of pathology.

[18]  Andrius Kazlauskas,et al.  Diverse Signaling Pathways Activated by Growth Factor Receptors Induce Broadly Overlapping, Rather Than Independent, Sets of Genes , 1999, Cell.

[19]  S. Maeda,et al.  Disruption of aldose reductase gene (Akr1b1) causes defect in urinary concentrating ability and divalent cation homeostasis. , 2000, Biochemical and biophysical research communications.

[20]  M Krook,et al.  Short-chain dehydrogenases/reductases (SDR). , 1995, Biochemistry.